Lifetime prevalence of psychotic and bipolar I disorders in a general population.
By Jonna Perälä, J. Suvisaari, S. Saarni, K. Kuoppasalmi, E. Isometsä, S. Pirkola, T. Partonen, A. Tuulio-Henriksson, J. Hintikka, T. Kieseppä and 3 more. Archives of General Psychiatry, 2007
1,495 citations recorded by the source corpus.
Subfields: Pharmacology, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/051b84a393d23fde956e6972d714eb49346317e7
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pharmacology
In Psychiatry and Mental health
Citations in the corpus
- Quality of the Finnish Hospital Discharge Register: A systematic review (2012, background): “Psychotic and bipolar disorders [47] 1969−2002 (2007) 692 − 75 88 PIF study, MR (DSM-IV-TR)”
- The prevalence of mental illness in refugees and asylum seekers: A systematic review and meta-analysis (2020, background): “5%) in refugees and asylum seekers appears to be less than the lifetime prevalence in general population samples: 16% [58] and 3% [59], respectively.”
- Gender Differences in Schizophrenia and First-Episode Psychosis: A Comprehensive Literature Review (2012, background): “However, the recent studies of prevalence of schizophrenia in general population did not find gender differences [5, 6].”
- An updated and conservative systematic review and meta-analysis of epidemiological evidence on psychotic experiences in children and adults: on the pathway from proneness to persistence to dimensional expression across mental disorders (2012, background): “The rate of PE is significantly greater than the comparable rate of psychotic disorder (Perälä et al. 2007).”
- Predicting Psychosis: Meta-analysis of Transition Outcomes in Individuals at High Clinical Risk (2013, background): “The Orwin fail-safe procedure estimated that 171 unpublished studies would be needed to make the overall meta-analytic estimate of transition risk nonsignificantly different from the base risk.(52)”
- Schizophrenia: a concise overview of incidence, prevalence, and mortality. (2008, background): “It should also be noted that several important studies related to incidence (75), prevalence (54), and mortality (76) have appeared since our reviews were published.”
- Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. (2008, background): “Schizophrenia affects nearly 1% of the population [1].”